Clinical efficacy and safety of triptoreline pamoate in the management of advanced prostate cancer in 1,432 patients: Results of a prospective noninterventional postmarketing surveillance study.
Phase of Trial: Phase IV
Latest Information Update: 05 Mar 2010
At a glance
- Drugs Triptorelin (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Mar 2010 Results were presented at ASCO 2010 Genitourinary Cancers Symposium.
- 05 Mar 2010 New trial record